Skip to main navigation Skip to search Skip to main content

Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma

  • Ashkan Lashkari
  • , Warren A. Chow
  • , Frances Valdes
  • , Lucille Leong
  • , Vu Phan
  • , Przemyslaw Twardowski
  • , Neena Kapoor
  • , Arturo Molina
  • , Zaid Al-Kadhimi
  • , Paul Frankel
  • , George Somlo

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

Background: Patients with locally advanced or metastatic/recurrent soft tissue and Ewing's sarcoma (EWS) have few treatment options. The purpose of our phase II study was to assess the feasibility, safety and efficacy of tandem high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT) in such patients. Patients and Methods: Thirteen patients were enrolled onto this study. The first cycle of HDCT consisted of doxorubicin (150 mg/m 2) and ifosfamide (14 g/m2) mixed with mesna (14 g/m 2), while the second cycle consisted of melphalan (150 mg/m 2) and cisplatin (200 mg/m2). Results: Eleven out of 13 patients were able to complete both cycles of HDCT. No treatment-related mortality occurred and grade 3 or 4 toxicity was clinically tolerable. The 5-year progression-free survival (PFS) and overall survival (OS) for all patients was 23% (confidence interval, CI: 0-46%) and 31% (CI: 14-70%), respectively. Out of the four patients still alive, two had EWS and measurable disease at the time of ASCT and achieved a complete remission, remaining progression free 126 and 155 months after ASCT. Conclusion: Our study demonstrates the feasibility and safety of tandem HDCT in patients with high-risk or metastatic/recurrent sarcoma, with some patients achieving long-term PFS and OS.

Original languageEnglish
Pages (from-to)3281-3288
Number of pages8
JournalAnticancer Research
Volume29
Issue number8
StatePublished - Aug 2009

Keywords

  • Autologous transplantation
  • Ewing's sarcoma
  • High-dose chemotherapy
  • Rhabdomyosarcoma

Fingerprint

Dive into the research topics of 'Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma'. Together they form a unique fingerprint.

Cite this